New York State Common Retirement Fund
SUPN icon

New York State Common Retirement Fund’s Supernus Pharmaceuticals SUPN Stock Holding History

New York State Common Retirement Fund’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Buy
51,862
+7,390
+17% +$355K ﹤0.01% 1388
2026
Q1 		$2.3M Hold
44,472
– – ﹤0.01% 1334
2025
Q4 		$2.21M Buy
44,472
+11,154
+33% +$542K ﹤0.01% 1357
2025
Q3 		$1.59M Sell
33,318
-4,492
-12% -$181K ﹤0.01% 1518
2025
Q2 		$1.19M Sell
37,810
-14,551
-28% -$466K ﹤0.01% 1596
2025
Q1 		$1.71M Hold
52,361
– – ﹤0.01% 1435
2024
Q4 		$1.89M Hold
52,361
– – ﹤0.01% 1442
2024
Q3 		$1.63M Sell
52,361
-3,300
-6% -$103K ﹤0.01% 1474
2024
Q2 		$1.49M Buy
55,661
+29
+0.1% +$841 ﹤0.01% 1581
2024
Q1 		$1.9M Buy
55,632
+4,085
+8% +$122K ﹤0.01% 1494
2023
Q4 		$1.49M Sell
51,547
-9,436
-15% -$250K ﹤0.01% 1595
2023
Q3 		$1.68M Buy
60,983
+123
+0.2% +$3.74K ﹤0.01% 1516
2023
Q2 		$1.83M Sell
60,860
-52,389
-46% -$1.83M ﹤0.01% 1527
2023
Q1 		$4.1M Sell
113,249
-87,243
-44% -$3.35M 0.01% 1264
2022
Q4 		$7.15M Buy
200,492
+4,939
+3% +$172K 0.01% 1030
2022
Q3 		$6.62M Sell
195,553
-45,966
-19% -$1.5M 0.01% 1033
2022
Q2 		$6.99M Buy
241,519
+142,453
+144% +$4.08M 0.01% 1034
2022
Q1 		$3.2M Sell
99,066
-4,378
-4% -$134K ﹤0.01% 1509
2021
Q4 		$3.02M Buy
103,444
+30,822
+42% +$935K ﹤0.01% 1558
2021
Q3 		$1.94M Sell
72,622
-639
-0.9% -$17.2K ﹤0.01% 1777
2021
Q2 		$2.26M Sell
73,261
-2,687
-4% -$82.4K ﹤0.01% 1798
2021
Q1 		$1.99M Hold
75,948
– – ﹤0.01% 1791
2020
Q4 		$1.91M Hold
75,948
– – ﹤0.01% 1711
2020
Q3 		$1.58M Buy
75,948
+7,034
+10% +$160K ﹤0.01% 1689
2020
Q2 		$1.64M Buy
68,914
+3,850
+6% +$85.1K ﹤0.01% 1616
2020
Q1 		$1.17M Buy
65,064
+20,764
+47% +$436K ﹤0.01% 1653
2019
Q4 		$1.05M Sell
44,300
-6,600
-13% -$160K ﹤0.01% 1936
2019
Q3 		$1.4M Sell
50,900
-157,301
-76% -$4.66M ﹤0.01% 1819
2019
Q2 		$6.89M Buy
208,201
+9,517
+5% +$326K 0.01% 1138
2019
Q1 		$6.96M Buy
198,684
+2,800
+1% +$104K 0.01% 1100
2018
Q4 		$6.51M Sell
195,884
-7,600
-4% -$327K 0.01% 1070
2018
Q3 		$10.2M Sell
203,484
-30,298
-13% -$1.5M 0.01% 997
2018
Q2 		$14M Buy
233,782
+21,900
+10% +$1.13M 0.02% 848
2018
Q1 		$9.7M Sell
211,882
-31,155
-13% -$1.3M 0.01% 999
2017
Q4 		$9.69M Sell
243,037
-15,639
-6% -$618K 0.01% 1007
2017
Q3 		$10.3M Sell
258,676
-51,989
-17% -$2.25M 0.01% 938
2017
Q2 		$13.4M Buy
310,665
+10,035
+3% +$357K 0.02% 841
2017
Q1 		$9.41M Sell
300,630
-15,800
-5% -$423K 0.01% 974
2016
Q4 		$7.99M Buy
316,430
+38,580
+14% +$862K 0.01% 1040
2016
Q3 		$6.87M Buy
277,850
+8,250
+3% +$187K 0.01% 1092
2016
Q2 		$5.49M Buy
269,600
+23,161
+9% +$411K 0.01% 1196
2016
Q1 		$3.76M Buy
246,439
+40,458
+20% +$528K 0.01% 1330
2015
Q4 		$2.77M Buy
205,981
+7,299
+4% +$113K ﹤0.01% 1474
2015
Q3 		$2.79M Buy
198,682
+7,013
+4% +$130K ﹤0.01% 1450
2015
Q2 		$3.25M Buy
+191,669
New +$2.73M ﹤0.01% 1597

Other funds holding SUPN

SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
VIM
VELA Investment Management New Albany, Ohio $468M AUM 18.47% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

New York State Common Retirement Fund's SUPN Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Supernus Pharmaceuticals (SUPN) stake by 17% in Q2 2026, buying an estimated $355K and bringing the position to 51,862 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1388.

New York State Common Retirement Fund first reported a position in SUPN in Q2 2015 and has held it in 45 quarters since. The position peaked at $14M in Q2 2018. 98 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • New York State Common Retirement Fund held 51,862 shares of Supernus Pharmaceuticals worth $2.41M as of Q2 2026.
  • New York State Common Retirement Fund bought 7,390 Supernus Pharmaceuticals shares in Q2 2026, an estimated $355K.
  • Supernus Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1388 holding.
  • New York State Common Retirement Fund first reported a position in Supernus Pharmaceuticals in Q2 2015 and has held it in 45 quarters since.
  • New York State Common Retirement Fund's Supernus Pharmaceuticals position peaked at $14M in Q2 2018.
  • 98 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.